Metamorphosis of a 35 Year-Old TRIGA Reactor into a Modern BNCT Facility

  • Iiro Auterinen
  • Pekka Hiismäki
  • Petri Kotiluoto
  • Rolf J. Rosenberg
  • Seppo Salmenhaara
  • Tiina Seppälä
  • Tom Serén
  • Vesa Tanner
  • Carita Aschan
  • Mika Kortesniemi
  • Antti Kosunen
  • Juha Lampinen
  • Sauli Savolainen
  • Matti Toivonen
  • Petteri Välimäki

Abstract

Using FiR 1, a 250kW TRIGA reactor as a neutron source for BNCT was screened as a viable option in 1990, as the future of the reactor was questioned. By the initiative of the medical radio isotope group at VTT the Finnish BNCT project started incorporating early on also the medical and medical physics sides.1,2 At first a thermal neutron source only was considered conceivable, but quite soon it was realized that using aluminum-aluminum fluoride moderator a high quality epithermal neutron source was quite feasible.3 After gaining support both from the medical community as well as from private and state financing sources a decision was made in 1994 to accomplish the necessary changes in the reactor and the reactor hall.

Keywords

Graphite Lithium Attenuation Boron Polyethylene 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. Hiismäki, I. Auterinen, and M. Färkkilä, The Finnish BNCT Program, An Overview, In: M. Kallio, and I. Auterinen (Eds.) Proceedings of the CLINCT BNCT Workshop. Helsinki: Helsinki University of Technology series TKK-F-A718, 2–4, 1994.Google Scholar
  2. 2.
    S. Savolainen, I. Auterinen, M. Kallio et al., The Finnish boron neutron capture therapy program-an overview on scientific projects, Excerpta Medica. International Congress Series 1132, Vol. 1, 342–347, 1997.Google Scholar
  3. 3.
    I. Auterinen, and P. Hiismäki, Epithermal BNCT neutron beam design for a Triga II reactor, In: H. Soloway, and R.F. Barth (Eds.) Advances in Neutron Capture Therapy. Proceedings of the 5th International Symposium on Neutron Capture Therapy. Columbus, OH, September 14–17, 1992. New York: Plenum Press 81–84, 1993,.CrossRefGoogle Scholar
  4. 4.
    I. Auterinen, P. Hiismäki, T. Serén, and T. Seppälä, Creating an Epithermal Neutron Field for BNCT Using a Triga Reactor and an Aluminum Fluoride Composite as Neutron Moderator, In: Proceedings of the 1998 ANS Radiation Protection and Shielding Division Topical Conference, Technologies for the New Century, April 19–23, 1998, Nashville, Tennessee, USA. ANS 1998, Vol. II, pp. 77–83.Google Scholar
  5. 5.
    P. Hiismäki, and I. Auterinen, Patent FI-92890 (1995).Google Scholar
  6. 6.
    K. Kaita, T. Serén, and I. Auterinen, First characterisation of the Finnish epithermal neutron beam using activation detectors, Excerpta Medica. International Congress Series 1132, Volume I, pp. 531–4, 1997.Google Scholar
  7. 7.
    D.W. Nigg, Y.D. Harker, J.K. Hartwell et al., Collaborative Spectral Characterization of the Finnish Epithermal-Neutron Beam Facility for BNCT, in: INEEL BNCT Research Program Annual Report 1996, INEL/EXT-97-00319, April 1997.Google Scholar
  8. 8.
    V. Tanner, I. Auterinen, J. Helin, and S. Savolainen, On line neutron beam monitoring of the Finnish BNCT Facility, Nucl. Instrum. (in press).Google Scholar
  9. 9.
    T. Seppälä, T. Serén, and I. Auterinen, Source characterization for the rtt_MC treatment planning program at FiR 1, (these proceedings).Google Scholar
  10. 10.
    M. Kortesniemi, A. Kosunen, T Serén et al., Phantom dose distributions in the beam of Finnish BNCT facility, (these proceedings).Google Scholar
  11. 11.
    A. Kosunen, M. Kortesniemi, H. Ylä-Mella et al., Twin ionization chambers for dose determination in phantom in an epithermal neutron beam, Radiat. Prot. Dosim. (in press).Google Scholar
  12. 12.
    J. Lampinen, T. Seppälä, I. Auterinen, and S. Savolainen, Three dose calculation codes applied to neutron transport in BNCT, (these proceedings).Google Scholar
  13. 13.
    F.W. Stallmann, LSL-M2: A Computer Program for Least-Squares Logarithmic Adjustment of Neutron Spectra, NUREG/CR-4349, ORNL/TM-9933, Oak Ridge March 1986.Google Scholar
  14. 14.
    S. Savolainen et al., Dosimetry chain for the dogs irradiated in the epithermal neutron beam at the Finnish BNCT facility, (these proceedings).Google Scholar
  15. 15.
    P. Kotiluoto, P. Hiismäki, I. Auterinen, T. Seppälä, and C. Aschan, Shielding design and calculations for the Finnish BNCT facility, (these proceedings).Google Scholar
  16. 16.
    J. Benczik et al., Large animal model for healthy tissue tolerance study in BNCT, (these proceedings).Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Iiro Auterinen
    • 1
  • Pekka Hiismäki
    • 1
  • Petri Kotiluoto
    • 1
  • Rolf J. Rosenberg
    • 1
  • Seppo Salmenhaara
    • 1
  • Tiina Seppälä
    • 1
    • 2
    • 3
  • Tom Serén
    • 1
  • Vesa Tanner
    • 2
    • 5
  • Carita Aschan
    • 2
    • 5
  • Mika Kortesniemi
    • 2
    • 3
  • Antti Kosunen
    • 2
  • Juha Lampinen
    • 2
  • Sauli Savolainen
    • 2
    • 5
  • Matti Toivonen
    • 4
  • Petteri Välimäki
    • 2
  1. 1.VTT Chemical TechnologyFinland
  2. 2.Department of PhysicsUniversity of HelsinkiFinland
  3. 3.Clinical Research InstituteHelsinki University Central HospitalFinland
  4. 4.STUK-Radiation and Nuclear Safety AuthorityFinland
  5. 5.Department of RadiologyHelsinki University Central HospitalFinland

Personalised recommendations